SUSTAINABILITY AND QUALITY IN THE PHARMACEUTICAL INDUSTRY: THE CRITICAL ROLE OF QUALITY ASSURANCE IN GREEN MANUFACTURING AND ENVIRONMENTAL STEWARDSHIP
DOI:
https://doi.org/10.22159/ijpps.2025v17i9.55633Keywords:
Sustainability, Pharmaceutical industry, Quality assurance (QA), Green chemistry, Pharma 4.0, Environmental stewardship, Life cycle assessment (LCA), Digital quality management, GMP, Total quality management (TQM)Abstract
The pharmaceutical industry, while essential to public health, contributes significantly to environmental degradation through energy-intensive processes, hazardous waste, and high carbon emissions. This review explores the evolving role of quality assurance (QA) as a strategic enabler of sustainability within pharmaceutical manufacturing. Traditionally focused on compliance and product integrity, QA is now expanding to incorporate green chemistry principles, environmental auditing, and sustainability metrics into quality systems. The integration of digital tools such as Digital Quality Management Systems (QMS), Artificial Intelligence (AI), and the Internet of Things (IoT), under the Pharma 4.0 framework, is transforming QA into a real-time, data-driven pillar of sustainable operations. The review emphasizes the implementation of life cycle assessments (LCA), eco-design strategies, renewable feedstocks, solvent recovery, and green documentation practices across the product lifecycle from R&D to distribution and disposal. It further highlights the importance of cross-functional collaboration, regulatory alignment, and stakeholder engagement in achieving green objectives. Despite promising innovations, the study identifies several barriers, including regulatory inflexibility, a lack of standardized green QA frameworks, and resistance to organizational change. Strategic enablers, including total quality management (TQM), employee empowerment, policy incentives, and environmental governance, are discussed as critical to embedding sustainability in quality systems. Ultimately, QA's alignment with environmental stewardship not only ensures regulatory compliance and operational efficiency but also fosters long-term corporate resilience and societal trust. By embedding sustainability into the pharmaceutical quality framework, this transformation supports the industry’s shift toward greener, more ethical, and future-ready manufacturing practices that align with global environmental and public health goals.
Downloads
References
1. Desai M, Njoku A, Nimo Sefah L. Comparing environmental policies to reduce pharmaceutical pollution and address disparities. Int J Environ Res Public Health. 2022 Jul 7;19(14):8292. doi: 10.3390/ijerph19148292, PMID 35886145, PMCID PMC9325029.
2. Bade C, Olsacher A, Boehme P, Truebel H, Burger L, Fehring L. Sustainability in the pharmaceutical industry an assessment of sustainability maturity and effects of sustainability measure implementation on supply chain security. Corp Soc Responsibility Env. 2024;31(1):224-42. doi: 10.1002/csr.2564.
3. Milanesi M, Runfola A, Guercini S. Pharmaceutical industry riding the wave of sustainability: review and opportunities for future research. J Clean Prod. 2020 Mar 19;261:121204. doi: 10.1016/j.jclepro.2020.121204.
4. Lee BX, Kjaerulf F, Turner S, Cohen L, Donnelly PD, Muggah R. Transforming our world: implementing the 2030 agenda through sustainable development goal indicators. J Public Health Policy. 2016 Sep;37Suppl 1:13-31. doi: 10.1057/s41271-016-0002-7, PMID 27638240.
5. Riikonen S, Timonen J, Sikanen T. Environmental considerations along the life cycle of pharmaceuticals: interview study on views regarding environmental challenges, concerns, strategies and prospects within the pharmaceutical industry. Eur J Pharm Sci. 2024 May 1;196:106743. doi: 10.1016/j.ejps.2024.106743, PMID 38460610.
6. Heberer T, Ternes TA. Pharmaceuticals and the environment. J Environ Manag. 2020 Nov 1;270:110702. doi: 10.1016/j.jenvman.2020.110702.
7. Nasrullah M, Khan SA, Hashmi MZ, Iqbal J. Green manufacturing, green chemistry and environmental sustainability: a review. Curr Res Environ Sustain. 2019;1:100003.
8. Karina Witte, Michael Muller. Sustainable pharmacy: a guiding principle. Sustainable Chemistry and Pharmacy. 2025 Apr;44:101897. doi: 10.1016/j.scp.2024.101897.
9. Belkhir L, Elmeligi A. Carbon footprint of the global pharmaceutical industry and relative impact of its major players. J Cleaner Prod. 2019 Mar 20;214:185-94. doi: 10.1016/j.jclepro.2018.11.204.
10. Olawade DB, Popoola TT, Egbon E, David Olawade AC. Sustainable healthcare practices: pathways to a carbon-neutral future for the medical industry. Sustain Futures. 2025 Jun;9:100783. doi: 10.1016/j.sftr.2025.100783.
11. Di Russo M, Zjalic D, Lombardi GS, Perilli A, Congedo G, Daugbjerg S. Impact of the 50 biggest pharma companies: a review of environmental report aspiring to NetZero. Eur J Public Health. 2023 Oct 1;33Suppl 2:ckad160.1182. doi: 10.1093/eurpub/ckad160.1182.
12. El Haouat Z, Essalih S, Bennouna F, Amegouz D. Development of a global framework for an integrated life cycle assessment (LCA) model in quality safety and environmental (QSE) management systems: improving environmental, social and economic sustainability performance. Sustainability. 2025 Apr 14;17(8):3521. doi: 10.3390/su17083521.
13. Sonu GM, Rani GM, Pathania D, Abhimanyu S, Umapathi R, Rustagi S. Agro-waste to sustainable energy: a green strategy of converting agricultural waste to nano-enabled energy applications. Sci Total Environ. 2023 Jun 1;875:162667. doi: 10.1016/j.scitotenv.2023.162667, PMID 36894105.
14. Saikiran P, Pawan Kumar T, Arya S, Tijare D, Loharkar S, Bajad G. Advances in pharmaceutical oral solid dosage forms. In: Jain K, Yadav AK, editors. In advances in pharmaceutical product development. Singapore: Springer Nature; 2025 Mar 19. p. 111-42. doi: 10.1007/978-981-97-9230-6_5.
15. Mustoe CL, Turner AJ, Urwin SJ, Houson I, Feilden H, Markl D. Quality by digital design to accelerate sustainable medicines development. Int J Pharm. 2025 Aug 20;681:125625. doi: 10.1016/j.ijpharm.2025.125625, PMID 40287074.
16. Agrawal M, Bansal A, Khandelwal VK, Bansal N. Sustainable pharma: the need, current status and mission for the future. Scr Med. 2024;55(4):489-99. doi: 10.5937/scriptamed55-51612.
17. Belal MM, Shukla V, Ahmad S, Balasubramanian S. Green Pharma supply chain: a review of existing practices and future directions. Manag Environ Qual. 2025;36(1):72-106. doi: 10.1108/MEQ-08-2023-0249.
18. Chaudhary M, Choudhary P, Tripathi A, Pandey VK, Sharma R, Singh S. Pharmaceutical orientation and applications of silver/zinc oxide nanoparticles developed from various fruit peel extracts: an emerging sustainable approach. Discov Sustain. 2025 Jan 6;6(1):7. doi: 10.1007/s43621-024-00728-y.
19. Chen Z, Lian JZ, Zhu H, Zhang J, Zhang Y, Xiang X. Application of life cycle assessment in the pharmaceutical industry: a critical review. J Cleaner Prod. 2024 May 11;459:142550. doi: 10.1016/j.jclepro.2024.142550.
20. Sinha M, Kumari P. Sustainability transformation through green supply chain in pharma industry. Int J Supply Oper Manag. 2021;8(2):123-32.
21. Diaz De Junguitu A, Allur E. The adoption of environmental management systems based on ISO 14001, EMAS, and alternative models for SMEs: a qualitative empirical study. Sustainability. 2019 Dec 9;11(24):7015. doi: 10.3390/su11247015.
22. Jindal R, Singh D. Integration of green chemistry principles in pharmaceutical production. Int J Green Chem. 2023;12(1):45-58.
23. Sharma V, Kumar A. Evaluating sustainability metrics for pharmaceutical quality systems. J Environ Chem Eng. 2022;10(2):124-34.
24. Priyadarshini D. Sustainable innovation in pharmaceutical manufacturing: future of medicine production. Curr Opin Green Sustain Chem. 2025;42:100872.
25. Pandey A, Joshi H. Optimizing quality standards in Pharma 4.0 by implementation of QMS. Int J Pharm Sci Rev Res. 2023;81(1):1-6.
26. Verma R, Gupta A. Digital transformation and Industry 4.0 in pharma manufacturing. J Pharm Technol. 2022;38(3):160-6.
27. Hasan M, Ali S. A systematic review of Industry 4.0 technologies in pharmaceutical manufacturing. Sustain Ind. 2023;2(1):1-12.
28. Kodumuru R, Sarkar S, Parepally V, Chandarana J. Artificial intelligence and internet of things integration in pharmaceutical manufacturing: a smart synergy. Pharmaceutics. 2025 Feb 22;17(3):290. doi: 10.3390/pharmaceutics17030290, PMID 40142954.
29. Kabir M, Rana MR, Debnath A. The role of quality assurance in accelerating pharmaceutical research and development: strategies for ensuring regulatory compliance and product integrity. J Angiother. 2024 Dec 8;8(12):1. doi: 10.25163/angiotherapy.81210102.
30. Ramanathan N. Embedding sustainability concerns into quality assurance. Total Qual Manag Bus Excell. 2025 Feb 17;36(3-4):249-63. doi: 10.1080/14783363.2020.1858712.
31. Milisavljevic Syed J, Khan M, Xia H, Li J, Salonitis K. Charting the course: standardization of quality assurance in digital twin applications across product lifecycle. Procedia CIRP. 2024 Jan 1;130:718-23. doi: 10.1016/j.procir.2024.10.154.
32. Faieq HT, Cek K. Enhancing kurdistans manufacturing companies sustainable waste management: a norm activation approach to green accounting, CSR, and environmental auditing oversight. Heliyon. 2024 Jun 30;10(12):e32725. doi: 10.1016/j.heliyon.2024.e32725, PMID 38975142.
33. Bhadoriya A, Patil B, Vinchurkar K, Mane S, Parambath A. Materials sustainability in the pharmaceutical industry. Sustainability & Circularity NOW. 2024;1:a24604207. doi: 10.1055/a-2460-4207.
34. Belal MM, Shukla V, Ahmad S, Balasubramanian S. Green pharma supply chain: a review of existing practices and future directions. Manag Environ Qual. 2025 Jan 29;36(1):72-106. doi: 10.1108/MEQ-08-2023-0249.
35. Chen Z, Lian JZ, Zhu H, Zhang J, Zhang Y, Xiang X. Application of life cycle assessment in the pharmaceutical industry: a critical review. J Clean Prod. 2024 May 11;459:142550. doi: 10.1016/j.jclepro.2024.142550.
36. Zhang B, Mohammad J. Sustainability of perishable food cold chain logistics: a systematic literature review. Sage Open. 2024 Sep;14(3):21582440241280455. doi: 10.1177/21582440241280455.
37. Ashiwaju BI, Orikpete OF, Fawole AA, Alade EY, Odogwu C. A step toward sustainability: a review of biodegradable packaging in the pharmaceutical industry. Matrix Sci Pharm. 2023;7(3):73-84. doi: 10.4103/mtsp.mtsp_22_23.
38. Awaysheh A, Klassen RD. The impact of supply chain structure on the use of supplier socially responsible practices. Int J Oper Prod Manag. 2010 Nov 16;30(12):1246-68. doi: 10.1108/01443571011094253.
39. Vian T, Kohler JC, Forte G, Dimancesco D. Promoting transparency accountability and access through a multi-stakeholder initiative: lessons from the medicines transparency alliance. J Pharm Policy Pract. 2017 Dec;10(1):18. doi: 10.1186/s40545-017-0106-x, PMID 28588896.
40. Hassan AS, Jaaron AA. Total quality management for enhancing organizational performance: the mediating role of green manufacturing practices. J Cleaner Prod. 2021 Jul 25;308:127366. doi: 10.1016/j.jclepro.2021.127366.
41. Bade C, Olsacher A, Boehme P, Truebel H, Burger L, Fehring L. Sustainability in the pharmaceutical industry an assessment of sustainability maturity and effects of sustainability measure implementation on supply chain security. Corp Soc Responsibility Env. 2024 Jan;31(1):224-42. doi: 10.1002/csr.2564.
42. Gul RF, Jamil K, Mustafa S, Jaffri NR, Anwar A. Mitigating the environmental concerns through total quality management and green manufacturing practices. Environ Sci Pollut Res Int. 2024 Jun;31(27):39285-302. doi: 10.1007/s11356-024-33826-5, PMID 38814557.
43. Hassan AS, Jaaron AA. Total quality management for enhancing organizational performance: the mediating role of green manufacturing practices. J Clean Prod. 2021 Jul 25;308:127366. doi: 10.1016/j.jclepro.2021.127366.
44. Ogbuagu OO, Mbata AO, Balogun OD, Oladapo O, Ojo OO, Muonde MU. Sustainable pharmaceutical supply chains: green chemistry approaches to drug production and distribution. IRE J. 2024 Oct;8(4):761-7.
45. Daughton CG. Cradle to cradle stewardship of drugs for minimizing their environmental disposition while promoting human health. I. rationale for and avenues toward a green pharmacy. Environ Health Perspect. 2003 May;111(5):757-74. doi: 10.1289/ehp.5947, PMID 12727606.
46. Kabir M, Rana MR, Debnath A. The role of quality assurance in accelerating pharmaceutical research and development: strategies for ensuring regulatory compliance and product integrity. J Angiotherapy. 2024 Dec 8;8(12):1. doi: 10.25163/angiotherapy.81210102.
47. Helwig K, Niemi L, Stenuick JY, Alejandre JC, Pfleger S, Roberts J. Broadening the perspective on reducing pharmaceutical residues in the environment. Environ Toxicol Chem. 2024 Mar 1;43(3):653-63. doi: 10.1002/etc.5563, PMID 36647735.
48. Karapetrovic S, Willborn W. Integration of quality and environmental management systems. TQM Mag. 1998 Jun 1;10(3):204-13. doi: 10.1108/09544789810214800.
49. Seymour EJ, Ridley AM, Noonan J. Assessing the role of a four-stage approach for improving the compatibility of environmental management systems and quality assurance. Aust J Exp Agric. 2007 Feb 12;47(3):333-45. doi: 10.1071/EA06026.
50. Battersby S. Quality management systems: environmental management systems as examples. In: clay’s handbook of environmental health. Routledge; 2022 Aug 16. p. 242-76.
51. Abbas J. Impact of total quality management on corporate green performance through the mediating role of corporate social responsibility. J Clean Prod. 2020 Jan 1;242:118458. doi: 10.1016/j.jclepro.2019.118458.
52. Giram PS, Gaikwad VV, Thonte SS, Rajurkar MR, Gholve SB, Bhusnure OG. Environmental protection by implementation of green purchasing, green productivity, green marketing and green quality management systems. Environ Manag. 2015 Aug 4;4(10):2005-28.
53. Gujral SK. Green marketing sustainable development. Int J Manag Soc Sci. 2016;4(3):66-70.
54. Bastas A. Sustainable manufacturing technologies: a systematic review of latest trends and themes. Sustainability. 2021 Apr 12;13(8):4271. doi: 10.3390/su13084271.
55. Deleryd M, Fundin A. Towards societal satisfaction in a fifth generation of quality the sustainability model. Total Qual Manag Bus Excell. 2025 Feb 17;36(3-4):292-308. doi: 10.1080/14783363.2020.1864214.
56. Chen H, Akparep J, Sulemana I, Osei A. Advancing green innovations in pharmaceutical firms towards societal development: nurturing customers health and building loyalty. Environ Dev Sustain. 2024 Nov 15:1-26. doi: 10.1007/s10668-024-05690-3.
57. Nahas N, Chandrasekar KS. Total quality management in pharmaceutical industry: with respect to green innovation. J Gujarat Res Soc. 2019;21(8):242-8.
58. Aboueid S, Beyene M, Nur T. Barriers and enablers to implementing environmentally sustainable practices in healthcare: a scoping review and proposed roadmap. Healthc Manage Forum. 2023 Nov;36(6):405-13. doi: 10.1177/08404704231183601, PMID 37357691.
59. Faisal M. Research analysis on barriers to green supply chain management in pharmaceutical industries. Review Pub Administration Manag. 2015;3(1):1-5. doi: 10.4172/2315-7844.1000176.
60. Zaman SI, Ali MR, Khan SA. Exploring interrelationships among barriers and enablers of green procurement for a sustainable supply chain. Int J Procurement Manag. 2024;19(2):226-52. doi: 10.1504/IJPM.2024.136051.
61. Chaturvedi U, Sharma M, Dangayach GS, Sarkar P. Evolution and adoption of sustainable practices in the pharmaceutical industry: an overview with an Indian perspective. J Clean Prod. 2017 Dec 1;168:1358-69. doi: 10.1016/j.jclepro.2017.08.184.
62. Belal MM, Shukla V, Ahmad S, Balasubramanian S. Green Pharma supply chain: a review of existing practices and future directions. Manag Environ Qual. 2025 Jan 29;36(1):72-106. doi: 10.1108/MEQ-08-2023-0249.
63. TS N, Bharath S, PN, BR M. Harmonizing quality and sustainability: a comprehensive analysis of total quality management and green manufacturing practices in small and medium-sized enterprises. Int J Lean Six Sigma. 2025 Feb 6. doi: 10.1108/IJLSS-10-2024-0236.
64. Fernandez Rivas DF, Cintas P. On an intensification factor for green chemistry and engineering: the value of an operationally simple decision-making tool in process assessment. Sustain Chem Pharm. 2022 Jun 1;27:100651. doi: 10.1016/j.scp.2022.100651.
65. Deleryd M, Fundin A. Towards societal satisfaction in a fifth generation of quality the sustainability model. Total Qual Manag Bus Excell. 2025 Feb 17;36(3-4):292-308. doi: 10.1080/14783363.2020.1864214.
66. Laddha PR, Sitaphale GR, Charhate KB, Tathe PR. Green chemistry in pharmaceutical synthesis: sustainable strategies for drug production. Intr J Adv Res Sci Commun Technol. 2024;4(2):323-30.
67. Sontakke GM, Sakhare SS, Chavan RD, Dhakne GS, Hamand VG. Quality control and quality assurance in pharmaceutical industry. Intr J Adv Res Sci Commun Technol. 2023;3(2):501-10.
Published
How to Cite
Issue
Section
Copyright (c) 2025 VINEETH RAJ K., RAVEESH GOPAL HEGDE, ANOOP NARAYANAN V.
This work is licensed under a Creative Commons Attribution 4.0 International License.
